Kaivola J - Search Results

1

Kaivola J, Nyman TA, Matikainen S. Kaivola J, et al. Viruses. 2021 Dec 14;13(12):2513. doi: 10.3390/v13122513. Viruses. 2021. PMID: 34960782 Free PMC article. Review.

2

Postnatal development of diazepam-insensitive [3H]Ro 15-4513 binding sites.

Korpi ER, Uusi-Oukari M, Kaivola J. Korpi ER, et al. Among authors: kaivola j. Neuroscience. 1993 Mar;53(2):483-8. doi: 10.1016/0306-4522(93)90212-x. Neuroscience. 1993. PMID: 8388087

3

IGFBP2 secretion by mammary adipocytes limits breast cancer invasion.

Conway JRW, Dinç DD, Follain G, Paavolainen O, Kaivola J, Boström P, Hartiala P, Peuhu E, Ivaska J. Conway JRW, et al. Among authors: kaivola j. Sci Adv. 2023 Jul 14;9(28):eadg1840. doi: 10.1126/sciadv.adg1840. Epub 2023 Jul 12. Sci Adv. 2023. PMID: 37436978 Free PMC article.

4

A feed-forward loop between SorLA and HER3 determines heregulin response and neratinib resistance.

Al-Akhrass H, Conway JRW, Poulsen ASA, Paatero I, Kaivola J, Padzik A, Andersen OM, Ivaska J. Al-Akhrass H, et al. Among authors: kaivola j. Oncogene. 2021 Feb;40(7):1300-1317. doi: 10.1038/s41388-020-01604-5. Epub 2021 Jan 8. Oncogene. 2021. PMID: 33420373 Free PMC article.

5

Effects of FGFR inhibitors TKI258, BGJ398 and AZD4547 on breast cancer cells in 2D, 3D and tissue explant cultures.

Kähkönen TE, Toriseva M, Petruk N, Virta AR, Maher A, Eigéliené N, Kaivola J, Boström P, Koskivuo I, Nees M, Tuomela JM, Ivaska KK, Härkönen PL. Kähkönen TE, et al. Among authors: kaivola j. Cell Oncol (Dordr). 2021 Feb;44(1):205-218. doi: 10.1007/s13402-020-00562-0. Epub 2020 Oct 29. Cell Oncol (Dordr). 2021. PMID: 33119860 Free PMC article.

6

Dexmedetomidine preconditioning ameliorates kidney ischemia-reperfusion injury.

Lempiäinen J, Finckenberg P, Mervaala EE, Storvik M, Kaivola J, Lindstedt K, Levijoki J, Mervaala EM. Lempiäinen J, et al. Among authors: kaivola j. Pharmacol Res Perspect. 2014 Jun;2(3):e00045. doi: 10.1002/prp2.45. Epub 2014 Apr 22. Pharmacol Res Perspect. 2014. PMID: 25505591 Free PMC article.

7

Discovery and structural characterization of a phospholamban-binding cyclic peptide and design of novel inhibitors of phospholamban.

Tilgmann C, Pollesello P, Ovaska M, Kaivola J, Pystynen J, Tiainen E, Yliperttula M, Annila A, Levijoki J. Tilgmann C, et al. Among authors: kaivola j. Chem Biol Drug Des. 2013 Apr;81(4):463-73. doi: 10.1111/j.1747-0285.2012.01409.x. Epub 2012 Jun 6. Chem Biol Drug Des. 2013. PMID: 22578098

8

[Care guidelines and legal system].

Kaivola J, Myllymäki K. Kaivola J, et al. Duodecim. 2004;120(24):2971-6. Duodecim. 2004. PMID: 15700598 Review. Finnish. No abstract available.

9

Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan: structure-response and binding analysis with analogs of levosimendan.

Levijoki J, Pollesello P, Kaivola J, Tilgmann C, Sorsa T, Annila A, Kilpeläinen I, Haikala H. Levijoki J, et al. Among authors: kaivola j. J Mol Cell Cardiol. 2000 Mar;32(3):479-91. doi: 10.1006/jmcc.1999.1093. J Mol Cell Cardiol. 2000. PMID: 10731446

10

Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy production.

Nissinen E, Kaheinen P, Penttilä KE, Kaivola J, Lindén IB. Nissinen E, et al. Among authors: kaivola j. Eur J Pharmacol. 1997 Dec 11;340(2-3):287-94. doi: 10.1016/s0014-2999(97)01431-3. Eur J Pharmacol. 1997. PMID: 9537825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page